Expert InterviewLLY
Slingshot members are talking to an expert! The topic is:
Exploring the role of Eli Lilly's Jaypirca (Pirtobrutinib) in Chronic Lymphocytic Leukemia (CLL) Management
Executed on:Oct 9, 2025 10:45 AM EDT
Call Duration:30 minutes
Expert Profile
ExpertBlinded Expert
Institution: Case Western Reserve University School of Medicine
- Clinical Professor at Case Comprehensive Cancer Center
- Treats over 50 patients a year with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL)
- Research interests are focused on early phase cancer therapeutics, cellular and immunotherapies for blood cancers and other non-malignant disorders; laboratory-based translational researches in normal and cancer stem cell signaling profiles and pre-clinical animal models for therapeutics.
Interview Goal
This call will discuss the current treatment landscape and the potential of Jaypirca (pirtobrutinib), a non-covalent (reversible) BTK inhibitor approved for the treatment of CLL.